Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$1.53B |
| 2 |
Procter & Gamble
PG
|
+$1.01B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$684M |
| 4 |
Zoom
ZM
|
+$534M |
| 5 |
Chewy
CHWY
|
+$491M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.07B |
| 2 |
ServiceNow
NOW
|
+$874M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$776M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$767M |
| 5 |
Apple
AAPL
|
+$719M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.32% |
| 2 | Healthcare | 10.4% |
| 3 | Consumer Discretionary | 8.1% |
| 4 | Communication Services | 7.82% |
| 5 | Financials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
Adtran
ADTN
$645M
| $1.55M | ﹤0.01% |
142,133
-278,189
| -66% | -$2.87M |
|
3727
BlackRock Floating Rate Income Trust
BGT
$325M
| $1.55M | ﹤0.01% |
141,313
-117,605
| -45% | -$1.25M |
|
3728
BioNTech
BNTX
$23.2B
| $1.55M | ﹤0.01% |
23,205
+9,553
| +70% | +$477K |
|
3729
OceanFirst Financial
OCFC
$1.96B
| $1.55M | ﹤0.01% |
87,721
+26,426
| +43% | +$423K |
|
3730
Kelly Services Class A
KELYA
$528M
| $1.54M | ﹤0.01% |
97,752
+6,198
| +7% | +$88.6K |
|
|
USX
3731
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $1.54M | ﹤0.01% |
257,316
-12,629
| -5% | -$57.7K |
|
3732
Gerdau
GGB
$10.1B
| $1.54M | ﹤0.01% |
657,137
-4,289,127
| -87% | -$8.14M |
|
3733
Koppers
KOP
$981M
| $1.54M | ﹤0.01% |
81,796
-127,954
| -61% | -$1.94M |
|
|
TBI
3734
Trueblue
TBI
$301M
| $1.54M | ﹤0.01% |
100,823
-41,084
| -29% | -$610K |
|
3735
Aurinia Pharmaceuticals
AUPH
$1.95B
| $1.54M | ﹤0.01% |
94,495
+38,712
| +69% | +$620K |
|
|
YARW
3736
Yarrow Bioscience, Inc. Common Stock
YARW
$101M
| $1.54M | ﹤0.01% |
247
-19
| -7% | -$129K |
|
3737
Global X SuperDividend REIT ETF
SRET
$230M
| $1.53M | ﹤0.01% |
65,292
-38,119
| -37% | -$824K |
|
|
UBX
3738
DELISTED
Unity Biotechnology
UBX
| $1.53M | ﹤0.01% |
17,660
+11,616
| +192% | +$861K |
|
3739
Domo
DOMO
$179M
| $1.53M | ﹤0.01% |
47,623
-15,693
| -25% | -$349K |
|
3740
HUTCHMED
HCM
$2.01B
| $1.53M | ﹤0.01% |
55,517
-50,257
| -48% | -$1.09M |
|
3741
Nu Skin
NUS
$253M
| $1.53M | ﹤0.01% |
39,917
-160,757
| -80% | -$5.17M |
|
|
SRE.PRB
3742
DELISTED
Sempra 6.75% Mandatory Convertible Preferred Stock, Series B
SRE.PRB
| $1.52M | ﹤0.01% |
15,627
+3,524
| +29% | +$357K |
|
|
AAN.A
3743
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $1.52M | ﹤0.01% |
33,594
-668,826
| -95% | -$30.4M |
|
3744
Central Pacific Financial
CPF
$1.02B
| $1.52M | ﹤0.01% |
94,991
+4,391
| +5% | +$69.7K |
|
|
NXG
3745
NXG NextGen Infrastructure Income Fund
NXG
$333M
| $1.52M | ﹤0.01% |
49,750
-10,062
| -17% | -$296K |
|
3746
TriplePoint Venture Growth BDC
TPVG
$188M
| $1.52M | ﹤0.01% |
148,050
-100,329
| -40% | -$869K |
|
|
WSR
3747
DELISTED
Whitestone REIT
WSR
| $1.51M | ﹤0.01% |
208,028
+27,569
| +15% | +$175K |
|
3748
BlackRock MuniYield Pennsylvania Quality Fund
MPA
$143M
| $1.51M | ﹤0.01% |
111,092
+2,339
| +2% | +$31K |
|
|
NRO
3749
Neuberger Real Estate Securities Income Fund Inc
NRO
$189M
| $1.51M | ﹤0.01% |
435,117
+4,308
| +1% | +$14K |
|
3750
Liberty Latin America Class C
LILAK
$1.66B
| $1.51M | ﹤0.01% |
186,373
+46,086
| +33% | +$392K |
|
Similar funds
Morgan Stanley's Q2 2020 Portfolio in Review
As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,644 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
- Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
- Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
- Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
- Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
- Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
- Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.
Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.